Mind Medicine's Price Target Increased to $29.15, Up 11.49% from Prior Estimate

Mind Medicine's (MNMD) average one-year price target has been revised to $29.15/share, an increase of 11.49% from the prior estimate of $26.15. This is based on an average of targets provided by analysts, ranging from $16.16 to $64.05/share. The average price target represents a 95.93% increase from the latest reported closing price of $14.88/share. The put/call ratio of MNMD is 0.20, indicating a bullish outlook.